192 related articles for article (PubMed ID: 32628631)
1. Fertility preservation in borderline ovarian tumor patients and survivors.
Poulain M; Vandame J; Tran C; Koutchinsky S; Pirtea P; Ayoubi JM
Horm Mol Biol Clin Investig; 2020 Jul; 43(2):179-186. PubMed ID: 32628631
[TBL] [Abstract][Full Text] [Related]
2. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
3. Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
Khiat S; Provansal M; Bottin P; Saias-Magnan J; Metzler-Guillemain C; Courbiere B
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():65-70. PubMed ID: 32784054
[TBL] [Abstract][Full Text] [Related]
4. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
[TBL] [Abstract][Full Text] [Related]
5. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
[TBL] [Abstract][Full Text] [Related]
6. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
7. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
8. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
9. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
11. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
12. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
13. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
[TBL] [Abstract][Full Text] [Related]
14. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F;
Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
[TBL] [Abstract][Full Text] [Related]
15. Time from referral to ovarian tissue cryopreservation in a cohort of Danish women.
Kristensen SG; Pors SE; Poulsen LC; Andersen ST; Wakimoto Y; Yding Andersen C
Acta Obstet Gynecol Scand; 2019 May; 98(5):616-624. PubMed ID: 30758835
[TBL] [Abstract][Full Text] [Related]
16. Fertility preservation in women with malignant and borderline ovarian tumors: Experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG).
Geoffron S; Lier A; de Kermadec E; Sermondade N; Varinot J; Thomassin-Naggara I; Bendifallah S; Daraï E; Chabbert-Buffet N; Kolanska K
Gynecol Oncol; 2021 Jun; 161(3):817-824. PubMed ID: 33812696
[TBL] [Abstract][Full Text] [Related]
17. Borderline ovarian tumors and fertility.
Nam JH
Curr Opin Obstet Gynecol; 2010 Jun; 22(3):227-34. PubMed ID: 20386444
[TBL] [Abstract][Full Text] [Related]
18. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
19. Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors.
Cosyns S; Van Moer E; De Quick I; Tournaye H; De Vos M
Arch Gynecol Obstet; 2024 May; 309(5):2143-2152. PubMed ID: 38494510
[TBL] [Abstract][Full Text] [Related]
20. Immature Oocyte for Fertility Preservation.
Son WY; Henderson S; Cohen Y; Dahan M; Buckett W
Front Endocrinol (Lausanne); 2019; 10():464. PubMed ID: 31379739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
